Table 5.
Unadjusted | Adjusted | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Inflammation score | ||||||
Mild | Reference | Reference | ||||
Moderate | 3.42 | 1.04 to 11.23 | 0.042 | 3.09 | 0.92 to 10.34 | 0.067 |
Severe | 5.52 | 2.18 to 13.99 | < 0.001 | 4.12 | 1.59 to 10.70 | 0.004 |
Age | 1.02 | 0.99 to 1.04 | 0.072 | |||
Male gender | 1.30 | 0.69 to 2.44 | 0.403 | |||
BMI | 1.01 | 0.96 to 1.07 | 0.540 | |||
SaO2%, at admission | 0.97 | 0.96 to 0.99 | 0.023 | |||
Charlson Comorbidity Index | ||||||
1 point | 0.92 | 0.37 to 2.31 | 0.870 | |||
2 points | 1.28 | 0.46 to 3.53 | 0.631 | |||
3 points | 1.62 | 00.67 to 3.86 | 0.272 | |||
4 points | 1.25 | 0.45 to 3.62 | 0.678 | |||
5 points | 1.31 | 0.45 to 3.79 | 0.611 | |||
6 points | 2.27 | 0.28 to 18.30 | 0.433 | |||
Lymphocyte count | 0.93 | 0.72 to 1.20 | 0.584 | |||
D-dimer | ||||||
1st tercile (0–246 ng/mL) | Reference | Reference | ||||
2nd tercile (247–574 ng/mL) | 2.61 | 1.14 to 5.97 | 0.023 | 2.24 | 0.95 to 5.26 | 0.063 |
3rd tercile (> 574 ng/mL) | 5.44 | 4.44 to 12.14 | < 0.001 | 3.01 | 1.28 to 7.05 | 0.011 |
Ferritin | ||||||
1st tercile (0–356 μg/L) | Reference | |||||
2nd tercile (356–875 μg/L) | 1.78 | 0.86 to 3.68 | 0.116 | |||
3rd tercile (> 875 μg/L) | 2.39 | 1.18 to 4.85 | 0.016 | |||
Troponin I | ||||||
1st tercile (0–6.6 ng/mL) | Reference | Reference | ||||
2nd tercile (6.7–24 ng/mL) | 2.46 | 1.08 to 5.60 | 0.032 | 2.42 | 1.04 to 5.60 | 0.039 |
3rd tercile (> 24 ng/mL) | 4.19 | 1.88 to 9.35 | < 0.001 | 2.69 | 1.06 to 6.82 | 0.037 |
Interleukin-6 | ||||||
1st tercile (0–4.4 pg/ml) | Reference | |||||
2nd tercile (4.5–38.8 pg/ml) | 1.74 | 0.84 to 3.60 | 0.134 | |||
3rd tercile (> 38.8 pg/ml) | 2.03 | 1.09 to 3.76 | 0.025 |
Definitions: HR, hazard ratio; 95% CI, 95% confidence intervals; BMI, body mass index; SaO2, oxygen saturation
Significant P values are in bold